Pityriasis rubra pilaris following inactivated SARS-CoV-2 vaccine (CoronaVac).

Zhang, Li-Wen; Wang, Wen-Ju; Fu, Li-Xin; Lu, Yong-Hong; Chen, Tao; Xu, Rong-Hua

Zhang, Li-Wen; Wang, Wen-Ju; Fu, Li-Xin; Lu, Yong-Hong; Chen, Tao; Xu, Rong-Hua.

Afiliación

Zhang LW; Department of Dermatovenereology, Chengdu Second People's Hospital, Chengdu, China.
Wang WJ; Department of Dermatovenereology, Chengdu Second People's Hospital, Chengdu, China.
Fu LX; Department of Dermatovenereology, Chengdu Second People's Hospital, Chengdu, China.
Lu YH; Department of Dermatovenereology, Chengdu Second People's Hospital, Chengdu, China.
Chen T; Department of Dermatovenereology, Chengdu Second People's Hospital, Chengdu, China.
Xu RH; Institute of Dermatology, Chengdu Second People's Hospital, Chengdu, China.

J Eur Acad Dermatol Venereol ; 37(3): e287-e288, 2023 03.

Article en En | MEDLINE | ID: mdl-36504416

Asunto(s)

Vacunas contra la COVID-19; COVID-19; Pitiriasis Rubra Pilaris; Humanos; COVID-19/prevención & control; Vacunas contra la COVID-19/efectos adversos; SARS-CoV-2

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Pitiriasis Rubra Pilaris / Vacunas contra la COVID-19 / COVID-19 Límite: Humans Idioma: En Revista: J Eur Acad Dermatol Venereol Asunto de la revista: DERMATOLOGIA / DOENCAS SEXUALMENTE TRANSMISSIVEIS Año: 2023 Tipo del documento: Article País de afiliación: China

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google